Dare Bioscience Inc (DARE)

[doogdilinger]

Luv it thnx crabclamjohn!

[crabclamjohn]

This is one of those tickers that is just going to explode all of a sudden and everyone will be chasing! IMO GLTU

[harry crumb]

Loaded some folks. Could be a 20x timer here! $$$

[Eurotradr]

Daré Bioscience Receives FDA Fast Track Designation for DARE-BV1 for the Treatment of Bacterial Vaginosis - https://finance.yahoo.com/news/dar-bioscience-receives-fda-fast-120010266.html

[Eurotradr]

Well DARE sure has gone quiet.

[doogdilinger]

Added a few even though bios are tough to predict

[alstocks]

8-k out, the co. associated with BILL Gates

has been officially acquired.... again, IMO,

Dare is a potentially great long, long, long

term stock to buy and hold ....

Good luck to all

[Eurotradr]

Daré Bioscience Regains Compliance with Nasdaq Minimum Bid Price Rule
https://finance.yahoo.com/news/dar-bioscience-regains-compliance-nasdaq-130010328.html

[malt66]

Hype. I'm a buyer at .8...All hype no tor.

[alstocks]

This is long, long, long term buy & hold, you

can’t look at this like an impatient otc trader.

I’m guessing that’s the reason this has had a

sell off from 1.7 to 1.2.... impatient traders

selling for a small loss and trying to find the

next runner.... BAYER, BILL Gates

Buy & hold

Good luck to all

[harry crumb]

This junk isnt going anywhere. If it had any chance whales would be all over this by now an would be like acad, 5.00 when that took off. Jeeze.

[alstocks]

So, 1.75 before CC.... now 1.20 after CC

down 35% for no real reason.... still fresh off

the great Bayer news and the news that Daré

is connected to BIll Gates....

Buying more.... a great long term buy here,

Imo.... this is not for the impatient

A true long term stock

Good luck to all

[evenpar]

Maybe they should avoid anymore CC? There better when they keep there mouths shut.... another week and will be under a dollar again.

[HokieHead]

Wouldn't be surprised it closes green. Great CC imo.

[alstocks]

I guess this is a pullback due to

No NEW news in the CC.... which is the norm

investors are always buying leading up to a CC

then when they don’t announce earth shattering

news during.... there is a sell off ....

imo, very good long long term buy here in the

1.40 range...

Good luck to all

[HokieHead]

Awesome CC, you could tell there was a shorter on the call lol. Adding more this AM on the pullback. This will be bought out by Bayer in the next year or two. Solid CC imo.

[HokieHead]

Looking forward to call at 430pm.

[DeliverySuccess]

this could do a ARWR and go from 2$ to 50. I rode that one up not all the way though

[zj3001]

They can do a 10m share offering and be valued the same as where we are now.

[DeliverySuccess]

right, sounds good think ill accumulate all year.

women still have sex in a recession.

also bayer commercial partner reduces chances of offerings

[zj3001]

That 300m is years out. $1m was given. $20m next step.

[DeliverySuccess]

im in for 2500 shares. looks like a possible 10 bagger if they get the 300 mil from bayer

[Discipline15]

Bubbling and ready to move higher.

Women's Viagra folks. Think easy $30+ before year end. Great investment imo. MC currently under $50mil

-Discipline

[HokieHead]

Looking for a big week heading in to CC tomorrow with company updates and Bayer news. I think this has been shorted down and should correct well over $2 by close tomorrow.

[alstocks]

D A R E, recent DD summary....

Bayer deal:

https://www.google.com/amp/s/www.marketwatch.com/amp/story/guid/1BFD85B2-F7C3-4AC7-B29F-9546B9C5D321

Bill gates association:

https://www.marketwatch.com/press-release/dare-bioscience-enters-into-agreement-to-acquire-microchips-biotech-including-its-first-in-class-wireless-user-controlled-drug-delivery-platform-2019-11-11?mod=mw_quote_news

News on bayer deal on BAYER website:

https://www.investor.bayer.com/en/nc/news/investor-news/investor-news/bayer-and-dare-bioscience-enter-into-exclusive-license-agreement-for-us-commercial-rights-to-inve/

Good luck to all

[screen shot]

"Under the agreement, Daré will receive an upfront payment and access to Bayer's clinical and market capabilities while retaining control over Ovaprene's development and regulatory approval process. Bayer receives the right to obtain exclusive rights to commercialize the product in the U.S. following completion of the pivotal clinical trial being undertaken by Daré. The licensing option becomes effective with a payment of USD 20 million from Bayer to Daré. Daré might be eligible to receive commercial milestone payments potentially totaling USD 310 million as well as double-digit tiered royalties on net sales."

[alstocks]

Now listed on Bayer website.......

https://www.investor.bayer.com/en/nc/news/investor-news/investor-news/bayer-and-dare-bioscience-enter-into-exclusive-license-agreement-for-us-commercial-rights-to-inve/

Good luck to all

[harry crumb]

Ok, kudos to dare. Positive findings here. Win most of them, lose a select few, lol yes we were short. Lets c where its at in 25 days or so an may consider a rather large purchase. Gl longs

[bakedog38]

Bought a position today in DARE ………………….

Looking for great things this year 2020 , GLTA , DARE$$$

[HokieHead]

One of the cheapest Biotechs trading with the most potential. Ask Bayer and Bill Gates

[alstocks]

D A R E is associated w/ BILL GATES & BAYER

& more & more peeps are finding out & buying

Here are the links:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153315306


Good luck to all

[Eurotradr]

Nice bounce premarket. Let's keep it going!!

[ClayTrader]

* * $DARE Video Chart 01-15-2020 * *

Link to Video - click here to watch the technical chart video

[HokieHead]

50 thousand share bid after hours at $1.64, 6% higher than today's close. Making a break for back over $2 tomorrow. C.C. will take it to new highs.

Great biotech to own in 2020.

[Golden Cross]

Loading zone for next Week $DARE

[alstocks]

Crazy/common sense speculation....

Bill Gates gives money to company abc

likely bill Gates & abc sign a whole bunch

of paperwork saying “u can’t take this $ &

blow it at blackjack” without my consent

Abc gets bought out by dare Bioscience

Bill Gates likely had to give consent...

Therefore bill Gates knows all about dare

Bayer & whatever else is going on....

Good luck to all

[Golden Cross]

Daré Bioscience Schedules Conference Call for January 22, 2020 to Discuss Ovaprene® Licensing Agreement and General Corpora...

Dare Bioscience (NASDAQ:DARE)
Intraday Stock Chart
Today : Wednesday 15 January 2020

Click Here for more Dare Bioscience Charts.
Daré Bioscience, Inc.(NASDAQ: DARE), a leader in women’s health innovation, today announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Wednesday, January 22, 2020, to discuss the recently announced licensing agreement with Bayer and Daré’s broader partnering strategy, and to provide a general corporate update.
To access the conference call via phone, dial [phone] (U.S.) or [phone] (international). The conference ID number for the call is 2855687. The live webcast can be accessed under “Events & Presentations" in the Investor Relations section of the Company's website at www.darebioscience.com. Please log in approximately 5-10 minutes prior to the call to register and to download and install any necessary software. To access the replay, please call [phone] (U.S.) or [phone] (international). The conference ID number for the replay is 2855687. The call and webcast replay will be available until February 5, 2020.

About Daré Bioscience

Daré Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s health. The company’s mission is to identify, develop and bring to market a diverse portfolio of differentiated therapies that expand treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of contraception, vaginal health, sexual health, and fertility.

Daré’s product portfolio includes potential first-in-category candidates in clinical development: Ovaprene®, a hormone-free, monthly contraceptive intravaginal ring whose U.S. commercial rights are under a license agreement with Bayer; Sildenafil Cream, 3.6%, a novel cream formulation of sildenafil to treat female sexual arousal disorder utilizing the active ingredient in Viagra®; DARE-BV1, a unique hydrogel formulation of clindamycin phosphate 2% to treat bacterial vaginosis via a single application; and DARE-HRT1, a combination bio-identical estradiol and progesterone intravaginal ring for hormone replacement therapy following menopause. To learn more about Daré’s full portfolio of women’s health product candidates, and mission to deliver differentiated therapies for women, please visit www.darebioscience.com.

Daré may announce material information about its finances, product candidates, clinical trials and other matters using its investor relations website (http://ir.darebioscience.com), SEC filings, press releases, public conference calls and webcasts. Daré will use these channels to distribute material information about the company, and may also use social media to communicate important information about the company, its finances, product candidates, clinical trials and other matters. The information Daré posts on its investor relations website or through social media channels may be deemed to be material information. Daré encourages investors, the media, and others interested in the company to review the information Daré posts on its investor relations website (https://darebioscience.gcs-web.com/) and to follow these Twitter accounts: @SabrinaDareCEO and @DareBioscience. Any updates to the list of social media channels the company may use to communicate information will be posted on the investor relations page of the company's website mentioned above.

Contacts:

Investors on behalf of Daré Bioscience, Inc.:
Lee Roth
Burns McClellan
[e-mail]
212.213.0006

OR

Media on behalf of Daré Bioscience, Inc.:
Jake Robison
Canale Communications
[e-mail]
619.849.5383

Source: Daré Bioscience

[Golden Cross]

$5+ Coming here!

[alstocks]

D A R E = BAYER & BILL GATES....

Bayer:

https://www.google.com/amp/s/www.marketwatch.com/amp/story/guid/1BFD85B2-F7C3-4AC7-B29F-9546B9C5D321


Bill Gates:

https://www.marketwatch.com/press-release/dare-bioscience-enters-into-agreement-to-acquire-microchips-biotech-including-its-first-in-class-wireless-user-controlled-drug-delivery-platform-2019-11-11?mod=mw_quote_news

[alstocks]

Yeah ... couldn’t resist, the double whammy of

BAYER... largest pharmaceutical company

&

Bill Gates, richest person on planet

Could not wait for lower.... I pulled trigger in

the 1.50 area

Good luck to all

[HokieHead]

Like I said, deal is way bigger than what the share price is showing. Needed a day of correction. Looking for 2s here by C.C. next week.

[alstocks]

Wow, they do have. BILL GATES connection

https://www.marketwatch.com/press-release/dare-bioscience-enters-into-agreement-to-acquire-microchips-biotech-including-its-first-in-class-wireless-user-controlled-drug-delivery-platform-2019-11-11?mod=mw_quote_news

Did not realize this....

Maybe not directly, but they are likely one phone

call away from the richest person on the planet

DARE

IM IN

Good luck to all

[~MulaGreen~]

My DARE BioTech pick for 2020.
It meets all my requirements (DD) for the great ride...

Giant Bayer and MultiBillionaire Bill Gates are in it...

Looking forward to nextweek CC regarding the Bayer $300M+ deal.

LongBull.

[alstocks]

I see this going higher also, but

have to clear through... a few things:

1) otc traders buying this in high 1 & low 2
expecting an “easy” 50 to 100 % gain &
now selling at a loss to find the next big
mover....

2) company is admitting selling some shares
which makes perfect sense

might add a starter in 1.20 area ....

if call confirms no toxic financing which

appears to be the case with only a 20 to 25

Million float..... again, this is a very good

LONG TERM play

Good luck to all

[HokieHead]

Should see a correction higher heading in to Conference Call next week. Company just given 9-10 figure deal with Bayer and trading for about a $35 million valuation. Big upside here in 2020 imo.


Daré Bioscience Schedules Conference Call for January 22, 2020 to Discuss Ovaprene(R) Licensing Agreement and General Corporate Update

8:00 AM ET 1/15/20 | GlobeNewswire

Daré Bioscience Schedules Conference Call for January 22, 2020 to Discuss Ovaprene(R) Licensing Agreement and General Corporate Update

SAN DIEGO, Jan. 15, 2020 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc.(NASDAQ: DARE), a leader in women's health innovation, today announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Wednesday, January 22, 2020, to discuss the recently announced licensing agreement with Bayer and Daré's broader partnering strategy, and to provide a general corporate update.

To access the conference call via phone, dial [phone] (U.S.) or [phone] (international). The conference ID number for the call is 2855687. The live webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.darebioscience.com. Please log in approximately 5-10 minutes prior to the call to register and to download and install any necessary software. To access the replay, please call [phone] (U.S.) or [phone] (international). The conference ID number for the replay is 2855687. The call and webcast replay will be available until February 5, 2020.

[Golden Cross]

Dip and rip time

[HokieHead]

$1.40's after hours. I think it recovers in a big way tomorrow. Needed today after yesterday's take off. 20-25m OS and a $1.50 PPS values this biotech at only $37 million. Deal with Bayer alone should see this move to 10x that for starters in 2020. Great long term hold imo.

Insane looking at this:

Under the agreement, Daré will receive an upfront payment and access to Bayer's extensive clinical and market capabilities while retaining control over Ovaprene's development and regulatory approval process. Bayer receives the right to obtain exclusive rights to commercialize the product in the U.S. following completion of the pivotal clinical trial being undertaken by Daré. If Bayer, in its sole discretion, makes payment to Daré of $20 million, which Daré intends to apply to reimbursement of clinical study costs, then the exclusive license to commercialize Ovaprene in the U.S. will become effective. Daré will also be entitled to receive commercial milestone payments potentially totaling $310 million, in addition to double digit tiered royalties on net sales.

[Eurotradr]

Trying to pull itself back up. Just need some volume.

[HokieHead]

This will be back over $1.75 tomorrow and over $2 by week's end. Agree, longer term this is going to go big. Great news.

[alstocks]

I’m sure bayer did a lot of research prior to

giving some joe schmo a milly bucks....

plus they signed off on a dual press release

It comes down to this.... if you are a long term

patient player.... BUY Daré..... if one is an

Impatient otc trader.... don’t buy....

Dare is a LONG term buy & gold